Bristol Myers Squibb to Participate in Citi’s 2024 Global Healthcare Conference
26 Novembro 2024 - 8:59AM
Business Wire
Bristol Myers Squibb (NYSE: BMY) today announced that the
company will participate in Citi’s 2024 Global Healthcare
Conference.
Christopher Boerner, Ph.D., board chair and chief executive
officer, will take part in a fireside chat on December 3, 2024. He
will answer questions about the company beginning at 8:00 a.m.
ET.
Investors and the general public are invited to listen to a live
webcast of the session by visiting http://investor.bms.com. An
archived edition of this session will be available following its
conclusion.
About Bristol Myers Squibb
Bristol Myers Squibb is a global biopharmaceutical company whose
mission is to discover, develop and deliver innovative medicines
that help patients prevail over serious diseases. For more
information about Bristol Myers Squibb, visit us at BMS.com or
follow us on LinkedIn, X, YouTube, Facebook, and Instagram.
corporatefinancial-news
View source
version on businesswire.com: https://www.businesswire.com/news/home/20241126806842/en/
Media: media@bms.com Investors:
investor.relations@bms.com
Bristol Myers Squibb (NYSE:BMY)
Gráfico Histórico do Ativo
De Out 2024 até Nov 2024
Bristol Myers Squibb (NYSE:BMY)
Gráfico Histórico do Ativo
De Nov 2023 até Nov 2024
